All News

Half of Adults with Severe Asthma Treated with Tezepelumab Discontinue OCS Use at 52 Weeks: Phase 3b WAYFINDER Trial
May 22, 2025

The WAYFINDER trial is the first to demonstrate the positive impact of the thymic stromal lymphopoietin antagonist on steroid-dependent severe asthma.

Atopic Dermatitis Burden in Older Adults May Surge by 2050: Daily Dose
May 22, 2025

Your daily dose of the clinical news you may have missed.

From Screening to Support: How PCPs Can Tackle PPD
May 21, 2025

ACOG 2025: Joy Baker, MD, urged primary care clinicians to screen early, refer confidently, and help change the statistics on maternal mental health.

Dupilumab Improves Asthma Control, HRQoL Regardless of Comorbid Th2 Inflammatory Disease
May 21, 2025

Data from the global RAPID registry provide real-world support for dupilumab efficacy in youths and adults with uncontrolled asthma and with or without CRS and/or nasal polyposis.

Johanna Finkle, MD, on Approaching Weight Loss Discussions with Reproductive-Aged Patients
May 21, 2025

ACOG 2025: Johanna Finkle, MD, shares strategies to start weight conversations with patients and build clinician confidence in counseling and treatment options.

Primary Care Clinicians Diagnose Nearly Half of Youth MDD, Report Reveals, Often During a Crisis
May 21, 2025

Youth depression is often diagnosed during crisis events, underscoring the need for primary care education and enhanced collaborative care resources.

FDA Narrows COVID-19 Vaccine Access to High-Risk Groups, Demands New Trials for Healthy Adults
May 21, 2025

The FDA's new approach to evaluating and approving COVID-19 vaccines will move the US away from a one-size-fits-all approach and closer to policy in other countries.

Elinzanetant Effective for VMS Across BMI, Smoking Status: Daily Dose
May 21, 2025

Your daily dose of the clinical news you may have missed.

PPD Screening, Medicaid Coverage, and Access to Care: A Q&A with Elizabeth Mollard, PhD
May 20, 2025

ACOG 2025: Elizabeth Mollard, PhD, discusses her research on how Medicaid policies influence postpartum depression screening rates.

Single Dose of Arexvy RSV Vaccine Shows 3-Year Protection in Older Adults: Daily Dose
May 20, 2025

Your daily dose of the clinical news you may have missed.